Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2024 | The impact of TA-TMA and eculizumab treatment on healthcare utilization for pediatric patients

Christopher Dandoy • 22 Apr 2024
EBMT 2024
General Antibodies Eculizumab

Christopher Dandoy, MD, MSc, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, discusses a study investigating healthcare costs for pediatric patients who develop transplant-associated thrombotic microangiopathy (TA-TMA) and the impact of treatment with eculizumab. The study revealed higher healthcare costs for TMA-affected patients compared to those without TMA, yet eculizumab treatment did not alter these costs. This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Alexion: Honoraria.

More from Christopher Dandoy

The diagnosis and management of TA-TMA in pediatric patients 2:12
The diagnosis and management of TA-TMA in pediatric patients
Christopher Dandoy • 22 Apr 2024
Cardiac complications after SCT 2:16
Cardiac complications after SCT
Christopher Dandoy • 23 Apr 2022
Sleep quality and weight loss in stem cell transplant recipients 2:04
Sleep quality and weight loss in stem cell transplant recipients
Christopher Dandoy • 23 Apr 2022
Patient-important outcomes in pediatric transplant recipients 1:44
Patient-important outcomes in pediatric transplant recipients
Christopher Dandoy • 23 Apr 2022

Related Videos

Opportunities and challenges for real-time AI decision support in transplant care 4:47
Opportunities and challenges for real-time AI decision support in transplant care
Amin Turki • 5 Sep 2025
How AI and digital innovation are transforming transplant care 4:02
How AI and digital innovation are transforming transplant care
Amin Turki • 5 Sep 2025
Bringing clinical trials to the community: current approaches at Sarah Cannon Research Institute 1:01
Bringing clinical trials to the community: current approaches at Sarah Cannon Research Institute
Krish Patel • 4 Sep 2025
Stem cell transplant in 2025: latest advances, improving GvHD, and key clinical trials 8:12
Stem cell transplant in 2025: latest advances, improving GvHD, and key clinical trials
Alexandra Gomez-Arteaga • 10 Sep 2025
The content of VJHemOnc is intended for healthcare professionals